Trials / Not Yet Recruiting
Not Yet RecruitingNCT05312853
Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease.
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Johannes Gutenberg University Mainz · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- —
Summary
Primary objective is to study the relevance of non-invasive test (NITs) in predicting disease stage (diagnostic biomarker) and outcome (predictive biomarker) in patients with suspected or established liver disease and cirrhosis.
Detailed description
Non-invasive tests (NITs) may complement and even reduce the need for liver biopsy in the diagnosis and follow up care of patients with chronic liver disease (CLD). NITs either include serum biomarkers (direct or indirect) or ultrasound-based tests, including vibration controlled transient elastography (VCTE), or a combination of both incorporated into several surrogate scores.
Conditions
Timeline
- Start date
- 2024-01-15
- Primary completion
- 2034-04-15
- Completion
- 2034-12-31
- First posted
- 2022-04-06
- Last updated
- 2024-01-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05312853. Inclusion in this directory is not an endorsement.